Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

P Soulié; L Trandafir; A Taamma; F Lokiec; E Brain; J P Delord; A Mita; J M Vannetzel; E Cvitkovic; J L Misset

doi:10.1097/00001813-199709000-00005

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

NobleID: NI9P38W12R02S79
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/8CD113F4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8CD113F4.svg?ark=w1%2F20260515%2F8CD113F4&value=id)](https://nobleid.org/work/w1/20260515/8CD113F4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Schedule-dependent paclitaxel tolerance/activity: data from a 7 day infusion phase I study with pharmacokinetics in paclitaxel refractory ovarian cancer.

NobleID: NI9P38W12R02S79
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/8CD113F4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8CD113F4.svg?ark=w1%2F20260515%2F8CD113F4&value=id)](https://nobleid.org/work/w1/20260515/8CD113F4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work